A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

NCT06854341 · clinicaltrials.gov ↗

COMPLETED

Status

5448

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Sponsor

Novartis Pharmaceuticals